Medicare Enrolled
Dr. Shawn Skeen, MD
Cardiovascular Disease · Waco, TX
Practice pattern: Electrophysiology & Remote— Practice combining electrophysiology and remote services
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Skeen from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Skeen? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Skeen
Dr. Shawn Skeen is a cardiovascular disease in Waco, TX, with 17 years in practice. Based on federal Medicare data, Dr. Skeen performed 5,634 Medicare services across 4,130 unique beneficiaries.
Between the years covered by Open Payments, Dr. Skeen received a total of $124,268 from 43 pharmaceutical and/or device companies across 890 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Skeen is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice▲ Top 13% volume in TX$ $124,268 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,634
Medicare services
Top 13% in TX for cardiovascular disease
4,130
Unique beneficiaries
$75
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~331 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 1,163 | $87 | $140 |
| Electrocardiogram (EKG), 12-lead | 998 | $10 | $140 |
| Chronic care management, first 20 min/month | 522 | $46 | $114 |
| Remote patient monitoring device, 30 days | 331 | $36 | $183 |
| Remote pacemaker monitoring, 90 days | 326 | $23 | $105 |
| Remote pacemaker/defibrillator monitoring, 90 days | 324 | $17 | $101 |
| Echocardiogram, transthoracic | 318 | $135 | $1,558 |
| Regadenoson injection (Lexiscan) for heart stress test | 208 | $40 | $70 |
| Chronic care management, additional 20 min/month | 130 | $35 | $101 |
| New patient office visit (45-59 min) | 119 | $114 | $225 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 108 | $49 | $537 |
| Programming of dual lead pacemaker system | 103 | $62 | $182 |
| Hospital follow-up visit, moderate complexity | 102 | $62 | $142 |
| Ultrasound of both sides of head and neck blood flow | 74 | $140 | $558 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 66 | $10 | $76 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 65 | $51 | $593 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 53 | $20 | $92 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 48 | $268 | $348 |
| EKG interpretation and report | 45 | $6 | $52 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 41 | $2 | $113 |
| Initial hospital admission, high complexity | 35 | $136 | $355 |
| Ultrasound study of arm and leg arteries | 32 | $52 | $400 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 31 | $1,841 | $6,891 |
| Nuclear medicine study of heart muscle blood flow by pet | 31 | $139 | $520 |
| Ultrasound of heart with probe in esophagus, with report | 29 | $80 | $488 |
| Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | 29 | $94 | $206 |
| Ultrasound of heart blood flow, valves and chambers | 28 | $13 | $176 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 26 | $397 | $3,228 |
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 21 | $934 | $4,495 |
| Cardiac catheterization | 21 | $223 | $4,269 |
| Ultrasound of heart, follow-up | 19 | $19 | $156 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 18 | $138 | $564 |
| Removal and replacement of dual lead permanent pacemaker | 16 | $272 | $1,485 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 16 | $1,084 | $2,718 |
| External shock to heart to regulate heart beat | 16 | $84 | $487 |
| Programming of single lead pacemaker system | 16 | $53 | $150 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 13 | $6 | $89 |
| Ultrasound of one leg arteries or artery grafts | 13 | $88 | $373 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 13 | $123 | $473 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 12 | $181 | $2,266 |
| Ultrasound evaluation of blood vessel with review by radiologist, initial vessel | 11 | $68 | $358 |
| Nuclear medicine study of heart muscle at rest and with stress and spect | 11 | $49 | $642 |
| Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 11 | $202 | $912 |
| Programming of multiple lead pacemaker system | 11 | $63 | $215 |
| New patient office visit (30-44 min) | 11 | $67 | $166 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
22.3% high complexity
10.3% medium
67.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$124,268
Total received (2018-2024)
Avg $17,753/year across 7 years
Top 5% in TX for cardiovascular disease
43
Companies
890
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$64,287 (51.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$59,981 (48.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$17,974
2023$14,729
2022$10,339
2021$14,525
2020$15,163
2019$23,703
2018$27,835
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$25,772
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$21,404
AstraZeneca Pharmaceuticals LP
$17,549
Penumbra, Inc.
$16,962
Medtronic, Inc.
$7,934
Boston Scientific Corporation
$6,927
Abbott Laboratories
$6,499
Medtronic Vascular, Inc.
$5,871
BIOTRONIK INC.
$4,121
Inari Medical, Inc.
$3,738
BOSTON SCIENTIFIC CORPORATION
$2,164
Philips Electronics North America Corporation
$689
Novartis Pharmaceuticals Corporation
$648
PFIZER INC.
$546
Shockwave Medical, Inc
$396
ABIOMED
$354
Arineta, Inc
$308
E.R. Squibb & Sons, L.L.C.
$248
ShockWave Medical, Inc
$218
Bayer HealthCare Pharmaceuticals Inc.
$178
HEARTFLOW, INC.
$169
Janssen Pharmaceuticals, Inc
$166
Novo Nordisk Inc
$158
Boehringer Ingelheim Pharmaceuticals, Inc.
$149
ACIST MEDICAL SYSTEMS, INC.
$148
Impulse Dynamics (USA) Inc.
$131
Tactile Systems Technology Inc
$124
Bayer Healthcare Pharmaceuticals Inc.
$116
ZOLL Respicardia, Inc.
$107
Actelion Pharmaceuticals US, Inc.
$95
Gilead Sciences, Inc.
$92
Merck Sharp & Dohme LLC
$41
AngioDynamics, Inc.
$39
Amarin Pharma Inc.
$39
Cardinal Health 200, LLC
$29
HeartFlow, Inc.
$22
Cardiovascular Systems Inc.
$21
Merck Sharp & Dohme Corporation
$20
Kiniksa Pharmaceuticals International, plc
$18
Terumo Medical Corporation
$16
Kiniksa Pharmaceuticals, Ltd.
$14
CVRx, Inc.
$14
Kowa Pharmaceuticals America, Inc.
$13
Top 3 companies account for 52.1% of total payments
Associated products mentioned in payments ›
(5027) Intact Vascular Und · (6554) Peripheral Vascular Undivided · (6571) Eagle Eye · ABRE · ACCOLADE · ACCOLADE SR · AMPLATZER Occluders · ANGIOJET · ASSURITY · AURYON LASER SYSTEM 100-120 VAC · AVEIR · Abre · Accent Pacemaker · Acticor · Acticor 7 VR-T DX · Advisa · Allure Quadra RF CRT Pacemaker · Amplia MRI · Arcalyst · Assurity Pacemaker · Azure · BIOMONITOR · BRILINTA · Barostim Neo System · CAMZYOS · CARDIOMEMS · CHANTIX · CLINICAL TRIAL PRODUCT · CONFIRM RX · COREVALVE EVOLUT R · CT THROMBECTOMY SYSTEM KIT · CardioGraphe · CardioMEMS HF System · CareLink · ClosureFast · Confirm Rx · CoreValve Evolut · Corlanor · Diamondback Peripheral · ELIQUIS · EMBLEM · EMBLEM MRI S-ICD · ENDOTAK · ENSITE · ENTRESTO · EP-WORKMATE · EP-WorkMate Recording System · ESSENTIO · Edora · Edora 8 DR-T · FARXIGA · FFRct · FLEXITOUCH · FLOWTRIEVER CATHETER · FORTIFY ASSURA · FRONTRUNNER XP CTO Catheter · Flexitouch Plus · GALLANT · GENERAL THERAPIES · GENERAL VASCULAR INTERVENTION · GENERAL BRADY · GENERAL THERAPIES · GENERAL VASCULAR INTERVENTION · GENERAL - BRADY · GENERAL - THERAPIES · GENERAL BRADY · GENERAL THERAPIES · General - Brady · General - Therapies · General - Vascular Access · GlideWire · HAWKONE · HawkOne · IGT D Coronary · INGEVITY · Impella · Indigo · Indigo System · Inventra · JARDIANCE · Kerendia · LATITUDE · LEQVIO · LUX DX · LUX-DX · LUX-Dx Insertable Cardiac Monitor · LifeVest · Livalo · MERLIN@HOME · MICRA · Micra · Mitra Clip system · Mozec NC PTCA Balloon · ONYX FRONTIER · OPSUMIT · OptiCross · Optimizer · Orsiro Mission · Ozempic · PCI Optimization · PERCLOSE PROGLIDE · Pacemakers · Penumbra System · Perclose ProGlide suture mediated closure system · Performa · PressureWire FFR · QT Vascular Chocolate PTA Balloon · Quadra Allure MP RF CRT Pacemkr · Quadra Assura CRT Defibrillator · RESONATE · RHYTHMIA · RXI SYSTEMS · Ranexa · Repatha · Resolute · Reveal LINQ · Rivacor · Rivacor 7 DR-T · Rybelsus · S · SQ RX · SQ RX PULSE GENERATOR · SQ-RX PULSE GENERATOR · SQRX PULSE GENERATOR · SYMPLICITY G3 · SelectSecure · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · Stellarex · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · UPTRAVI · VALITUDE · VALITUDE CRT-P · VARITHENA · VERQUVO · VIEWMATE · VIGILANT · VYNDAQEL · Varithena Administration Pack · Vascepa · Vascular Lithotripsy · VenaSeal · WALLSTENT · WATCHMAN · WATCHMAN Access System · XARELTO · Xience Sierra Coronary Stent · ZOOM · remede System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (52%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 5% for cardiovascular disease in TX.
Equivalent to $2,206 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
18
Per 100K population
6.8
County median income
$63,888
Nearest hospital
ASCENSION PROVIDENCE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Skeen is a electrophysiology & remote specialist, with above-average Medicare volume (top 13% in TX), and high industry engagement (speaking/promotional, top 5%), with 17 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Skeen experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Skeen performed 1,163 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Skeen receive payments from pharmaceutical companies?
Yes. Dr. Skeen received a total of $124,268 from 43 companies across 890 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Skeen's costs compare to other cardiovascular diseases in Waco?
Dr. Skeen's average Medicare payment per service is $75. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Skeen) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Waco
Browse cardiovascular diseases in Waco ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in TX
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in TX
Which TX cardiovascular diseases receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc..
By company
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) Payments to Doctors
See all physicians who received payments from ZOLL Services LLC (A/K/A ZOLL LifeCor Corp).
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology